Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Karimeh Haghani Salar Bakhtiyari |
| Publication date | November 28, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |